Metabolic effects of an AT1-receptor blockade combined with HCTZ in cardiac risk patients: a non interventional study in primary care

BACKGROUND: The reduction of blood pressure alone does not eliminate the increased risk of arterial hypertension. Whilst concomitant metabolic risk factors have been shown to be responsible, the available pharmacotherapy has differential effects on these metabolic risk factors. For example, diuretic...

Descripción completa

Detalles Bibliográficos
Autores principales: Bramlage, Peter, Schönrock, Eleonore, Odoj, Peter
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588554/
https://www.ncbi.nlm.nih.gov/pubmed/19000308
http://dx.doi.org/10.1186/1471-2261-8-30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588554/
https://www.ncbi.nlm.nih.gov/pubmed/19000308
http://dx.doi.org/10.1186/1471-2261-8-30

Ejemplares similares